GENEDX HOLDINGS CORP (WGS)
US81663L2007 - Common Stock
GeneDx to Participate in Upcoming Investor Conferences
GeneDx to Participate in Upcoming Investor Conferences
GeneDx (Nasdaq: WGS) today announced that company management will participate in two upcoming investor conferences in June....
Tuesday Sector Leaders: Diagnostics, Paper & Forest Products
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GeneDx Hldgs (NASDAQ:WGS) just reported results for the first quarter of 2024.G...
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2024....
Tuesday Sector Leaders: Diagnostics, Biotechnology Stocks
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision...
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time. ...
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today...
GeneDx to Participate in 44th Annual Cowen Health Care Conference
GeneDx to Participate in 44th Annual Cowen Health Care Conference
GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. ...
Top Buys by Directors: Ryan's $161.4K Bet on WGS
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023....
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
GeneDx management will host a conference call at 4:30 p.m. Eastern Time on February 20, 2024 to discuss 2023 results and share full year 2024 guidance....
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STAMFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today...